Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Understand the detailed steps in financial planning that can help you create a solid foundation for your financial future. Start planning today!
21,266 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
One AI stock sits at the intersection of great product momentum and misunderstood AI economics. This piece explains w...
Palantir has a large revenue backlog, a major Army contract on the books, and ambitious growth guidance. This analysi...
Carvana stock has faced a rough start to 2026, with the headline move being a sizable drop. This guide breaks down wh...
Bitcoin has fallen out of step with broad money growth, creating a large gap between its price and M2-derived fair va...
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
Momentum can flip quickly in growth stocks, but today some names look cheap for the upside potential. This guide high...
Two concrete signals could shape the S&P 500 this week in the wake of Signet Jewelers' earnings. This guide explains ...
Oil prices rebounded today, lifting energy stocks. ExxonMobil led gains as the market priced in stronger cash flow, s...
Oil prices surge on geopolitical tensions, lifting energy stocks. This article examines a single ETF that could benef...
Geopolitics just accelerated volatility in energy markets. The rejection of a ceasefire proposal by iran has traders ...